UK Healthcare Update

Newmark - Global Healthcare Services (GHS) stands by its commitment to lowering the US healthcare costs through effectively utilizing real estate assets and restructuring capital. GHS Co-Leader and Executive Managing Director, Garth Hogan has recently toured facilities and met with UK private hospital executives as well as leaders of healthcare foreign capital interested in acquiring assets in the US. Healthcare expenditure across France, Germany and UK is at or near 10% of GDP, which is a higher figure than their transportation, construction and education, yet their outcomes are still better than the US where the healthcare spend is at or near 18% and growing. In the midst of healthcare reform uncertainty and indecision on Capitol Hill, there is a lot that can be learned from observing the successes and challenges of the UK’s National Health Service (NHS) and its partnership/integration with private hospitals and care. With an increase of an aging population, European medical tourism and a continued shift from public to private care, the UK has its own challenges and opportunities. Our GHS healthcare partners in the London Knight Frank office, led by Julian Evans has seen a record year in consulting transactions completed with an encouraging 2018 outlook to be even better. More to come on this subject in the December edition of the Pulse.

Harley Street Clinic, Central London


All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter